Mandatory text for non medical professionals —
Instillagel 6 ml/11 ml
Active substance:
Lidocaine hydrochloride 1 H2O, Chlorhexidine digluconate, Methyl-4-hydroxybenzoate, Propyl-4-hydroxybenzoate.
Composition:
| 6 ml/11 ml gel contains | 6 ml | 11 ml |
| Lidocaine hydrochloride 1 H2O | 125.40 mg | 230.00 mg |
|
Chlorhexidine digluconate |
3.14 mg | 5.75 mg |
| Methyl 4-hydroxybenzoate (Ph.Eur.) | 3.76 mg | 6.90 mg |
| Propyl 4-hydroxybenzoate (Ph.Eur.) | 1.57 mg | 2.87 mg |
Other ingredients:
Hyetellose, propylene glycol, sodium hydroxide, purified water
Indications:
Sterile gel with a local anaesthetic and disinfectant effect. For instillation. As a gel for mucous membrane disinfection and for local anesthesia, e.g., during catheterization, probe insertion, including intra-operatively, all forms of endoscopy, fistula catheter replacement, intubation, including for ventilation, for the prevention of iatrogenic damage to the rectum and colon.
Instillagel 6ml/11ml is suitable for use in adults and children aged 2 years and above.
For risks and side effects, read the package leaflet and ask your doctor or pharmacist.
Warnings:
Contains propylene glycol.
FARCO-PHARMA GmbH, Gereonsmühlengasse 1–11, 50670 Cologne, Germany
Effective date 01/2025
Mandatory text for medical professionals —
Instillagel 6 ml/11 ml, Gel
Active substance:
Lidocaine hydrochloride 1 H2O, Chlorhexidine digluconate, Methyl-4-hydroxybenzoate, Propyl-4-hydroxybenzoate.
Composition:
| 6 ml/11 ml gel contains | 6 ml | 11 ml |
| Lidocaine hydrochloride 1 H2O | 125.40 mg | 230.00 mg |
|
Chlorhexidine digluconate |
3.14 mg | 5.75 mg |
| Methyl 4-hydroxybenzoate (Ph.Eur.) | 3.76 mg | 6.90 mg |
| Propyl 4-hydroxybenzoate (Ph.Eur.) | 1.57 mg | 2.87 mg |
Other ingredients:
Hyetellose, propylene glycol, sodium hydroxide, purified water
Indications:
Urological product: Sterile gel with a local anaesthetic and disinfectant effect for instillation. As a gel for mucous membrane disinfection and for local anaesthesia, e.g. during catheterisation, probe insertion, including intra-operatively, all forms of endoscopy, fistula catheter replacement, intubation, including for ventilation, for the prevention of iatrogenic damage to the rectum and colon and in paediatric patients.
Instillagel 6 ml/11 ml is indicated in adults and children aged 2 years and above.
Contraindications:
Do not use Instillagel 6 ml/11 ml
- in the presence of known hypersensitivity to lidocaine and other local anaesthetics of the amide type,
- in patients with significant disorders of the heart’s conduction system,
- in patients with known hypersensitivity (allergy) to the active substances or to any of the excipients of Instillagel 6 ml/11 ml,
- in children under 2 years.
Undesirable effects:
Very rare: Allergic reactions (in the most serious cases, anaphylactic shock) to a local anaesthetic of the amide type and/or to chlorhexidine; Hypersensitivity reactions, including late-onset reactions, to chlorhexidine and/or methyl- or propyl-4-hydroxybenzoate.
Not known: Corneal erosion, epithelial defect/corneal injury, severe permanent visual impairment; Despite the proven wide safety range of Instillagel 6 ml/11 ml, systemic adverse effects of the local anaesthetic lidocaine, such as anaphylactic shock, a fall in blood pressure, bradycardia or seizures, are possible in the case of severe urethral damage.
Warning:
Contains propylene glycol.
More information: See SmPC and PIL.
FARCO-PHARMA GmbH, Gereonsmühlengasse 1–11, 50670 Cologne, Germany
Effective date: 09/2024